Prosecutors accused Actelion Pharmaceuticals, which Johnson & Johnson acquired in 2017, of violating Medicare laws by funneling money through a patient-assistance charity.
Drug Maker Pays $360 Million to Settle Investigation Into Charity Kickbacks
